218 - Experimental Therapeutics

Moderator(s)

• 

  Haley Pritchard, MD, MS (she/her/hers)

  Assistant Professor of Clinical Medicine
  Department of Medicine, Section of Infectious Diseases
  Indiana University School of Medicine
  Indianapolis, IN, United States
• 

  Jason Bowling, MD (he/him/his)

  Professor of Medicine
  University of Texas Health San Antonio
  San Antonio, TX, United States

Presentations:

• 10:30 AM – 10:42 AM US ET

  In Vivo Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), Against Seasonal Subtypes of Influenza in Prophylaxis in Immune Competent Mice, and in a Severe Immunodeficient (SCID) Mouse Model
  

  Presenting Author: James Levin, PhD – Cidara Therapeutics

  Co-Author: Simon Döhrmann, PhD – Cidara Therapeutics

  Co-Author: Jason N. Cole, Ph.D. – Cidara Therapeutics

  Co-Author: Karin Amundson, BSc – Cidara Therapeutics

  Co-Author: Allen Borchardt, PhD – Cidara Therapeutics

  Co-Author: Thomas P. Brady, Ph.D. – Cidara Therapeutics

  Co-Author: Thanh Lam, PhD – Cidara Therapeutics

  Co-Author: Joanne Fortier, BSc – Cidara Therapeutics

  Co-Author: Amanda Almaguer, Bachelors – Cidara Therapeutics

  Co-Author: Leslie W. Tari, Ph.D. – Cidara Therapeutics
• 10:42 AM – 10:54 AM US ET

  Elucidating the Gram-Positive Selective Spectrum Activity of Ibezapolstat; Secondary Analysis from the phase 2a trial
  

  Co-Author: Chris Lancaster, MS – University of Houston

  Co-Author: Jacob McPherson, PharmD – University of Houston College of Pharmacy

  Co-Author: M Jahangir Alam, PhD – Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA

  Co-Author: Khurshida Begum, PhD – Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA

  Co-Author: Md Ekramul Karim, MSc – Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA

  Co-Author: Chenlin Hu, PhD – University of Houston

  Co-Author: Eugenie Basseres, PhD – University of Houston College of Pharmacy

  Presenting Author: Kevin W. Garey, PharmD, MS (he/him/his) – University of Houston
• 10:54 AM – 11:06 AM US ET

  In Vitro Susceptibility of Recent Mycobacterium abscessus Isolates to Epetraborole (EBO) and Comparators by Broth Microdilution
  

  Presenting Author: Minh-Vu H. Nguyen, MD, M.Sc. (he/him/his) – National Jewish Health

  Co-Author: Vinicius Calado Nogueira de Moura, M.Sc. – National Jewish Health

  Co-Author: Tiffany Keepers White, PhD (she/her/hers) – AN2 Therapeutics

  Co-Author: Charles L. Daley, MD – National Jewish Health
• 11:06 AM – 11:18 AM US ET

  Efficacy of D-peptide-conjugated Antisense Compounds Against Pseudomonas aeruginosa
  

  Presenting Author: Rachelle E. Koch, M.S. (she/her/hers) – University of Texas Southwestern Medical Center

  Co-Author: Dina A. Moustafa, Ph.D. – Emory University School of Medicine

  Co-Author: Christine A. Pybus, MS – UT SOUTHWESTERN MEDICAL CENTER

  Co-Author: Joanna B. Goldberg, Ph.D. – Emory University School of Medicine

  Co-Author: David E. Greenberg, MD – UT Southwestern
• 11:18 AM – 11:30 AM US ET

  Synergistic Bacteriophage-Antibiotic Combinations Against High Inoculum DNS MRSA
  

  Presenting Author: Ashlan J. Kunz Coyne, Pharm.D., MPH – University of Kentucky

  Co-Author: Kyle Stamper, B.S. – Wayne State University

  Co-Author: Callan Bleick, PharmD (she/her/hers) – Anti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, Wayne State University School of Medicine, Department of Microbiology and Immunology, Detroit, MI

  Co-Author: Arnold S. Bayer, MD – Lundquist Institute-Harbor UCLA Medical Center

  Co-Author: Susan Lehman, PhD – Center for Biologics Evaluation and Research, US Food and Drug Administration

  Co-Author: Michael J. Rybak, PharmD, PhD, MPH – Eugene Applebaum College of Pharmacy and Health Sciences
• 11:30 AM – 11:43 AM US ET

  Preclinical Characterization of Rationally Designed Microbial Consortia to Prevent Bacterial Infections in Patients with Chronic Liver Disease
  

  Presenting Author: Elizabeth Halvorsen, PhD – Seres Therapeutics

  Co-Author: Marin Vulić, PhD – Seres Therapeutics

  Co-Author: Kelsey Barrasso, PhD – Seres Therapeutics

  Co-Author: Nicholas Beauchemin, n/a – Seres Therapeutics

  Co-Author: Jessica Brown, n/a – Seres Therapeutics

  Co-Author: Nathaniel J. Ennis, n/a – Seres Therapeutics

  Co-Author: Melissa Mayol, n/a – Seres Therapeutics

  Co-Author: Jenna I. Wurster, PhD (she/her/hers) – Seres Therapeutics

  Co-Author: Edward J. O'Brien, PhD – Seres Therapeutics

  Co-Author: Christopher Ford, PhD – Seres Therapeutics, Inc

  Co-Author: Matthew Henn, PhD – Seres Therapeutics, Cambridge, MA